Bank Of America Corp Protalix Bio Therapeutics, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 111,164 shares of PLX stock, worth $131,173. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111,164
Previous 114,560
2.96%
Holding current value
$131,173
Previous $144,000
9.72%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PLX
# of Institutions
64Shares Held
5.83MCall Options Held
103KPut Options Held
4.6K-
Israel Englander Millennium Management LLC | New York, Ny811KShares$957,1680.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny805KShares$949,4280.0% of portfolio
-
Goldman Sachs Group Inc New York, NY462KShares$545,1100.0% of portfolio
-
Gsa Capital Partners LLP London, X0435KShares$513,5510.03% of portfolio
-
Northern Trust Corp Chicago, IL423KShares$499,3910.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $58.7M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...